This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Bradykinin sensitizes TRPV1 channels in peptidergic nociceptors primarily via the bradykinin receptor 2 pathway, involving Ca(2+)-dependent exocytotic recruitment of TRPV1 channels trafficked by αCGRP-loaded large dense core vesicles. Silencing αCGRP expression significantly reduces this sensitization, highlighting its key role.
Why it matters
Understanding how bradykinin increases pain receptor sensitivity helps identify new targets for pain relief, especially by blocking the exocytosis process that increases pain channel presence on nerve cells.
How the study worked
The study used molecular and cellular techniques to assess TRPV1 sensitization in peptidergic nociceptors, including inhibition of Ca(2+)-dependent exocytosis and gene silencing of αCGRP and substance P to determine their roles in bradykinin-induced effects.
What this study cannot tell us
The study type and evidence strength are not specified, and the findings are primarily from cellular models which may not fully represent complex in vivo pain mechanisms.
Read the original research
Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors.
Frontiers in pharmacology, 7, 178
Citation
Mathivanan, Sakthikumar; Devesa, Isabel; Changeux, Jean-Pierre; Ferrer-Montiel, Antonio. (2016). Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors.. Frontiers in pharmacology, 7, 178. https://doi.org/10.3389/fphar.2016.00178